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A B S T R A C T
Objective: Characterization of nano-hydroxyapatite (n-HAp) silica gel bone substitute and evaluation of its
combined effect with Solcoseryl paste on bone formation experimentally in New Zealand rabbits.
Materials and methods: Characterization of the n-HAp silica gel granules (NanoBone®, Artoss GmbH, German)
was done by the SEM, EDX analysis and TEM. Simulated bone defect (10× 5×1mm) was constructed from
metallic mold to standardize the amount of the grafting materials. Two defects (10× 5×1mm) were created in
the parietal bones of 12 New Zealand White rabbits. The rabbits were randomly divided into 4 groups with 3
rabbits/group (n= 6 defects/group). Group (C): The defects were left empty for natural bone healing (control
group), group (S): The defects were filled with the pre-weighed Solcoseryl® paste (Legacy Pharmaceuticals
Switzerland GmbH, Switzerland), group (N): the defects were filled with the pre-weighed NanoBone and group
(SN): the defects were filled with Solcoseryl paste/NanoBone mixture (1:1 by Vol. %). The rabbits were sacrified
on day 14; the defects were removed, prepared for histological assessment and histomorphometric analysis. The
amount of bone formation was statistically analyzed by ANOVA and Post-hoc test (p < 0.05).
Results: The SEM revealed the highly rough, porous n-HAp silica gel granules. The TEM revealed the inter-
connected porosities within the silica matrix and the platelet like shape of the n-HAp crystals. The Ca: P ratio of
the n-HAp silica gel granules was 1.74. Histological evaluation revealed absence of new bone formation in group
C while calcification in most of osteoid tissue areas was evident in all experimental groups with evident wide
bone marrow cavities in S group. The NS group possessed the highest significant bone area percentage.
Conclusions: The interconnected porosities and the highly rough surface of n-HAp silica gel granules provided
biomimetic bone substitute material that promotes new bone formation. Solcoseryl/NanoBone mixture (1:1 vol
%) has a synergistic osteoinductive effect quantitatively and qualitatively on bone formation.
Clinical significance: Acceleration of post-operative bone healing in certain clinical cases where physiologic or
pathologic conditions could impair the vascularization process.
1. Introduction
Autogenous bone is considered as the gold standard for bone graft
materials and still preferred by the surgeons as it provides os-
teoinductive growth factors, osteogenic cells, and a structural scaffold
[1]. However, procurement morbidity and restrictions on obtainable
quantities limit its use [2]. Allografts are the next best substitute;
nevertheless, minor immunogenic rejection and risk of disease trans-
mission are unsolved issues [3]. Although synthetic grafting materials
eliminate these risks, the materials do not transmit osteoinductive or
osteogenic elements to the host site. Therefore, the market of bioma-
terials is expanding rapidly to cope with the higher demands for the
biological requirements of bone graft substitute materials. During the
past 30 years, biomaterials development have been focused on pro-
viding bioactive properties, osteogenic potential, easy degradation in
biological fluids and decreasing unfavorable immunological responses.
Therefore, a great diversity of synthesized bone graft substitutes such as
calcium phosphate materials namely; hydroxyapatite (HA) and β-tri-
calcium phosphate (β-TCP) have been developed and utilized in the
treatment of bone defects. Although these biomaterials belong to the
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same family, there are differences between the product properties, e.g.
porosity, crystallinity, phase purity, thermal and mechanical stability.
The required application will determine the desired properties of the
selected biomaterials [4].
The use of these synthetic calcium phosphate materials for the
treatment of osseous defects is encouraged by the fact that human bone
consists of a large portion of hydroxyapatite (inorganic phase).
However, during the manufacturing of these bioceramics, the sintering
temperature (1100 °C−1500 °C) results in a higher density of the ma-
terial and decreased porosity [5]. Furthermore, the pores inter-con-
nectivity is lost to a considerable degree with subsequent limited or no
biomaterial degradation and decreased osteoconductivity [6]. The
drawbacks of such behavior are the negative impact on mechanical
properties and sometimes the problem of chronic inflammation related
to the un-resorbed materials.
Nanotechnologies provide new materials in the nanometer range
(< 100 nm) with various potential applications in medical and dental
fields. Due to their distinctive size-dependent characteristics, nano-
structured bone graft materials could offer a better alternative to bulk
bone grafts. Nano-hydroxy appetite (n-HAp) silica gel bone graft ma-
terial has been introduced in the dental market since 2005 and con-
tinues with great clinical success until now [7–9]. The nanostructure of
this synthetic material simulates the natural hydroxyapatite crystals in
hard tissues which have been described to be nano-scaled plate-like or
rod-like crystals [10]. Additionally, this bone grafting substitute con-
sists of n-HAp in the presence of nanoporous silica (SiO2) formed by a
sol–gel method. By accomplishing a highly porous structure, a good
osteoconductivity was detected. It has been demonstrated that such
material is biodegraded by osteoclasts in a manner similar to the re-
modeling process of natural bone [6,11,12]. However, limited or no
information is available in the literature regarding its behavior in
combination with some bone healing promoting agents.
Solcoseryl is a biologically and chemically standardized protein free
non-antigenic and non-pyrogenic dialysate of blood from healthy veal
calves. Solcoseryl was developed in Solco Basle Research laboratories,
Switzerland, as a consequence of the search for humoral factors con-
trolling growth. Solcoseryl is composed of broad spectrum of low mo-
lecular weight organic and inorganic materials that facilitate wound
healing through controlling metabolic disturbances and tissue damage
associated with stress injury and hypoxia. Solcoseryl increases oxygen
uptake by cells, improves glucose transport, stimulates ATP synthesis,
stimulates collagen formation, and promotes angiogenesis [13]. It has
growth-factor-like activity and cytoprotective effects that accelerate the
return of reversibly damaged cells to their normal state [14].
In dentistry, earlier studies tried the utilization of Solcoseryl in ar-
tificial mandibular fractures in dogs. They reported that the fractures of
the Solcoseryl-treated group healed more rapidly than those of the
control group, and that Solcoseryl effectively heals fractures according
to the histological findings related to the healing process [15,16]. Re-
cently, Solcoseryl dental adhesive paste is used to enhance the healing
process of dry socket, denture ulcers, stomatitis as well as the healing
around dental implants [17,18].
In accordance with the ongoing development in the field of nano-
technology and the great interest in improving the regenerative
capacity of synthetic bone substitute biomaterials, the following study
has been conducted to characterize the chemical composition and mi-
crostructure of nano-hydroxy appetite (n-HAp) silica gel bone substitute
material and evaluating its combined effect with Solcoseryl paste on
bone formation experimentally in New Zealand rabbits. The hypothesis
of the current study was that the use of Solcoseryl and n-HAp silica gel
mixture would enhance the process of bone formation in New Zealand
rabbits.
2. Materials & methods
Detailed description of the utilized synthetic bone substitute mate-
rial and Solcoseryl pates as obtained from the manufacturers is pre-
sented in Table 1.
2.1. Characterization of n-HAp silica gel granules
Representative samples of the n-HAp silica gel granules were che-
mically analyzed with the scanning electron microscope (ESM, Model
Quanta 250 FEG, Field Emission Gun, accelerating voltage 30 KV. FEI
Company, Netherlands) fitted with the energy dispersive X-ray analyses
(EDX), using accelerating voltage 30 K.V., (magnification14x up to
1000000 and resolution for Gun.1n). Additionally, the SEM was used to
detect the average size of the n-AHp crystals and the porosities between
them.
Furthermore, representative sample of the n-HAp silica gel granules
was embedded in epoxy resin to prepare thin slices by the ultra-
microtomy (Ultracut, Germany). In an attempt to better observe the
silica gel matrix, additional sample of n-HAp silica gel granules was
dissolved in ethylenediaminetetraacetic acid (EDTA, Gama Dent, Gama
Lab., Egypt) and then both samples were imaged with the High re-
solution transmission electron microscope (TEM, YEOL 2100, Japan) to
reveal the average pore size distribution of the interconnected pores.
Sample size calculation was done according to an animal study
made by Wong R and Rabie B in 2007 [19]. Based on that study the
total sample size should be≥ 24 to detect significant effect size 0.8
with power of 80% and Alpha of 0.05, G power 3.1software. Accord-
ingly, a total of 24 bony defects were created in the parietal bones of 12
New Zealand White rabbits (2 defects/rabbit). The rabbits were ran-
domly divided into 4 groups with 3 rabbits in each group (n=6 de-
fects/group); 3 experimental groups and one control group as detailed
later (section 2.3).
2.2. Standardization of the amount of n-HAp silica gel granules and
Solcoseryl paste and their mixture
Rectangular metallic mold was prepared to simulate the planed
bony defect (10×5×1mm) dimension. The mold was sterilized and
filled with n-HAp silica gel granules (NanoBone® Artoss GmbH,
German) then the granules were placed on a sterile paper pad to be
weighed by the electronic balance to a precision of 10−4 g (Precise
Instrument ltd, Switzerland). According to the number of the bony
cavities that will be filled with the n-HAp silica gel granules, 6 sterilized
containers were filled with equal amount of n-HAp silica gel granules
Table 1
Detailed discerption of the materials used in the current study.
Material and Manufacturer Composition Batch no.
(NanoBone® Artoss GmbH, German). Granules of 76% nanocrystalline hydroxyapatite and 24% nanostructured silica (SiO2).The
nanocrystalline hydroxyapatite is loosely packed and connected by a silica gel. The porosity exceeds 80%
with pore sizes being 10–20 nm. The pores are highly interconnected resulting in a very large surface area
(84m2/g).
00–1351
Solcoseryl paste (Legacy Pharmaceuticals Switzerland
GmbH, Switzerland).
Contains a wide range of natural low molecular weight substances 10,000 daltons (glycolipids,
nucleotides, amino acids, oligopeptides, minerals, electrolytes and intermediate products of carbohydrate
and fat metabolism).
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then were used in the day of the surgical operation. Regarding to
Solcoseryl paste (Legacy Pharmaceuticals Switzerland GmbH,
Switzerland), a pre-weighed sterile syringe was used to fill up the me-
tallic mold with the paste then the filled syringe was re-weighed with
the electronic balance to calculate and standardize the amount of the
paste needed to fill up the bony cavities in Wt. %. Six syringes filled
with equal amounts of Solcoseryl paste were prepared for the day of the
surgical operation. Finally, the Solcoseryl paste and n-HAp silica gel
granules mixture was prepared in 1:1 ratio by volume and mixed by a
sterile spatula on a sterile paper pad. Six sterile sealed containers were
filled with equal amount of the mixture to be used in the day of the
surgical operation.
2.3. Experimental and control groups
Following the protocol of Wong R and Rabie B [19–21], a total of 24
full-thickness bone defects were created in the parietal bones of 12 New
Zealand White rabbits from an inbred colony. The rabbits were 5
months old (adult stage) and weighed 3.5–4.0 kg. The handling of the
animals and the experimental protocol were approved by the Institu-
tional Animal Care and Use Committee (CU-IACUC), Cairo University
(CU III S 21 16).
The rabbits were divided into 4 groups; 3 experimental groups (S, N,
SN) and one control group (C), with 3 rabbits in each group. In the
experimental group (S): the 6 defects were filled with the previously
calibrated amount (0.05 ml=0.16g) of Solcoseryl paste only. In the
experimental group (N): the 6 defects were filled with the previously
calibrated amount (0.034 g) of n-HAp silica gel granules only. In the
experimental group (SN): the 6 defects were filled with the mixture of
Solcoseryl paste (0.08g) and n-HAp silica gel granules (0.017 g) in a
ratio of 1:1 by volume. Finally, in group (C): the 6 defects were left
empty to act as a control group for natural bone healing.
2.4. Surgical procedures
After induction of anesthesia using sodium pentobarbitone, the site
of surgery was disinfected using Betadine, followed by draping. Local
anesthetic solution was injected using Articaine 4% with epinephrine
1:100000. A midline incision was made using Bard Parker blade no. 15
in a layered fashion till the bone is reached. Two full-thickness cranial
defects (10X5X1 mm), devoid of periosteum were created using tem-
plates in both parietal bones of each rabbit. The defects were produced
by round stainless steel burs with adequate speed dental drill
(2500 rpm). Initially, defects outlines were made by making holes of
full thickness at the parietal bones using a stainless steel wire template
bent to the required size of the defect [19–21]. Afterwards, the holes
were connected to complete the outline of the defect. During bone
cutting, irrigation with copious amount of sterile saline was used to
minimize thermal damage of the tissues. The defects were grafted with
the study materials or left empty according to the group in which the
rabbit is belonging to (Fig. 1A-F).
2.5. Postoperative care
All wounds were closed with interrupted 3/0 black silk sutures.
Periosteum approximation was not performed to prevent the barrier
effect. Postoperatively, the rabbits were given oxytetracycline hydro-
chloride/day (200mg/ml, 30mg/kg body weight) as an antibiotic and
buprenorphine hydrochloride (0.3 ml/kg body weight) for analgesia for
3 days. The animals were sacrified with sodium pentobarbitone for
merciful death euthanasia, 2 weeks after surgery and the defects with
the surrounding tissue were removed for histological preparation.
2.6. Specimen preparation for microscopic examination
Immediately after sacrifice of the experimental animals, the parietal
bones were removed and fixed in 10% formalin, after which they were
decalcified in EDTA for 4 weeks. Then, they were processed by routine
histological procedures to obtain paraffin embedded tissue sections (5μ
thick). The obtained sections were stained by hematoxylin and eosin (H
&E) stains, for histological examination and histomorphometric ana-
lysis. Moreover, the slides were stained histochemically by Masson
trichrome to detect calcified bone trabeculae and collagen fibers.
2.7. Histomorphometric analysis
The stained sections were assessed by ordinary light microscope and
image analyzer computer system using the software Leica Qwin 500
(Leica Microsystems, Switzerland). Five random fields in each specimen
were captured using a magnification (x400) to determine the area
percent of newly formed bone. The cursor was used to outline the areas
of the newly formed bone trabeculae, which were then masked by a
binary colour that could be measured by the computer. The image
analyzer was calibrated automatically to transform the pixels (mea-
surement units) produced by the image analyzer program into actual
micrometer units.
2.8. Statistical analysis
The data obtained from the computer image analyzer were pre-
sented as mean values and standard deviation (SD) for statistical ana-
lysis. The ANOVA test was used to compare the mean values of the area
percent of newly formed bone among the groups. The significant dif-
ference of the ANOVA test was followed by Post-hoc test, which per-
formed a pair-wise comparison between each studied group versus the
other. P-value was considered significant at 95% confidence interval
when p < 0.05. Statistical analysis was performed with IBM® SPSS®
Statistics Version 20 for Windows.
3. Results
3.1. Chemical analysis
The chemical composition of n-HAp silica gel granules obtained
from EDX analysis is presented in atomic and weight percentages (At.
and Wt. %, respectively) as seen in Fig. 2. The Ca: P ratio (At. %) was
calculated and the average of 3 samples was 1.74.
3.2. Imaging of the nano-hydroxy appetite silica gel granules
The images obtained from the SEM revealed the platelet like shape
of the nano-hydroxy appetite silica gel granules. The presented granules
have a mean length of 436.3 μm and a mean diameter of 214.5 μm
(Fig. 3A). The granules exhibited high surface roughness and porous
structure as seen in Fig. 3B and C respectively. On the other hand, the
TEM images of the embedded n-HAp silica gel (SiO2) granules in epoxy
revealed the shape and distribution of the n-HAp crystals within the
silica gel matrix at different magnifications (Fig. 4A and B). However, it
is not possible to differentiate between silica gel and epoxy. Therefore,
the suspension of the n-AHp silica gel granules with in EDTA was im-
aged by the TEM (Fig. 5A-C) at different magnifications. After partial
dissolution of the n-HAp crystals, the porous silica gel matrix was evi-
dent where the pore size distribution of the interconnecting pores was
around 20 nm.
3.3. Clinical and physical examinations
During the course of the study, all rabbits remained healthy and
recovered rapidly after operation. There were no signs of side effects or
infections in any of the rabbits.
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3.4. Histopathological findings
Regarding the control (C) group, the bony defects were clearly ob-
served. They were filled with connective tissue stroma in which few
areas of osteoid tissue were detected reflecting irrelevant spontaneous
bone healing. The periphery of the bony defect was mainly formed of
thick compact bone as seen in Fig. 6A. Meanwhile, in the experimental
groups, the bony defects in the Solcoseryl (S) group were totally filled
with osteoid tissue surrounded by plump cells in connective tissue
stroma. This finding represented the initial scaffold of new bone for-
mation. Calcification in the centers of osteoid areas was also evident.
About 1/3 of the defects revealed thin trabeculae of bone; extending
from the margin of the bony defect. These trabeculae were either se-
parate or forming a network enclosing wide bone marrow cavities,
containing fibro-vascular marrow with dilated blood vessels (Fig. 6B
and C). On the other hand, in the NanoBone (N) group, areas of osteoid
tissue and woven bone surrounded by plump cells in connective tissue
were a constant finding in the central area of the bony defects, (Fig. 6D
and E). In comparison to the S group, the osteoid areas showed an in-
creased number and larger size. The central calcifications were more
obvious than those of the S group. In addition, thick network of bone
trabeculae enclosing marrow cavities, filled with fibro-vascular marrow
were detected. These trabeculae were extending from the normal bony
margin, with an attempt to fill the bony defect. Numerous reversal lines
were revealed denoting active remodeling of the newly formed bone.
Enclosed osteocytes within lacunae denoting bone vitality were also
observed. In the combined Solcoseryl and NanoBone (SN) group, the
histopathological findings were close to those of the N group to a great
extent (Fig. 6F). However, areas of osteoid tissue and woven bone in
connective tissue stroma occupying the center of the defect were ob-
served only in ½ of the cases. All the examined cases showed thick
network of lamellar bone trabeculae enclosing narrow marrow cavities,
which succeeded to fill the bony defect totally in 2 out of 6 cases. In
comparison to N group, the bone trabeculae were thicker and enclosing
narrower marrow spaces.
3.5. Histochemical findings
In the control (C) group, the bony defects were clearly observed.
They were filled with connective tissue stroma and surrounded by
calcified compact bone as shown in Fig. 7A. Calcification in most of the
osteoid tissue areas was evident in all the experimental groups (S, N and
SN) as represented for the SN groups in Fig. 7B. On the other hand, the
network of bone trabeculae in both N and combined groups were well
calcified, similar to the normal bony margin, from which they were
extending. Decalcified bone was only observed at the peripheries of
osteocytic lacunae within bone trabeculae.
3.6. Histomorphometric analysis (quantitative analysis)
The lowest mean value of the area percentage of the newly formed
bone was detected in the control (C) group. In contrast, a gradual in-
crease in the mean area percentage of newly formed bone was observed
from the S group to the N group, until reaching its highest values in the
combined SN group. A highly significant difference (P- 0.0001) was
found upon comparing the area percentage of the newly formed bone
among the control and all experimental groups (Table 2). All the pair-
wise comparisons between each 2 groups showed a significant differ-
ence (P < 0.05). These values were represented in a bar chart (Fig. 8).
4. Discussion
The development of biomaterials and techniques that shorten the
initial bone and soft tissue healing period may improve the quality of
patient's life. Procedures that accelerate postoperative formation of
bone into dental implants site, cystic bony defects or even extraction
sockets, lead to early restoration of the patient's occlusion and provides
good potential for higher success rate for selected treatment option
[17].
New Zealand rabbits are one of the most frequently used animals for
health research. The ease of handling and the appropriate size with the
minimal stated differences between human and rabbit bone
Fig. 1. Surgical procedures include the followings: A) and B) creation of two 10X5X1 mm full-thickness cranial defects, devoid of periosteum, C) filling defects with
Solcoseryl paste (S) group, D) filling defects with NanoBone granules (N) group, E) filling defects with Solcoseryl and NanoBone mixture (SN) group, F) after suturing
of surgical wound.
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composition and density facilitate their wide use in musculoskeletal
research studies (about 35%) [22,23]. Additionally, the rabbits are
characterized by faster skeletal changes and bone turnover when
compared with other species such as some rodents and primates
[24,25]. Therefore, New Zealand rabbits were selected as experimental
animals in the present study. Moreover, the age of the experimental
animals is considered as an important factor in the designing of an
experimental animal model. It has been reported that spontaneous re-
generation is faster in young animals than in adult animals [26,27].
Subsequently, the development of an experimental model concerned
with studying the craniofacial malformations in animals must be done
using adult animals to minimize the growth effect. Therefore, adult
New Zealand rabbits i.e. 5 months old (adult stage) were used in the
current study.
Parietal bone defects was used for studying the combined effect of
Solcoseryl and n-HAp silica gel (NanoBone) on bone formation in New
Zealand rabbits because such anatomic area has limited mechanical
stresses and relatively stable surrounding structures. Thus, creating a
protected environment in which it is possible to study the interactions
between newly formed bone and in situ bone [28,29]. The critical size
defects created in the rabbit parietal bone were 10mm by 5mm based
on well-established protocol done in previous studies [19–21,30]. The
non-grafted bone defects (control group) will heal in a few months'
time, they revealed minimal bone healing after 14 days from their
creation (Fig. 6A) as compared to the experimental groups (Fig. 6B-F).
Therefore, these defects can only be used for investigating early bone
healing processes. Additionally, there was minimal morbidity due to
this procedure as all the rabbits were in good health condition after the
surgery. Furthermore, a previous study revealed that on the fourteenth
day, radiographs of simple fractures in rabbit tibiae showed formation
of dense periosteal bridging callus. However, cortices were not yet
healed, but bridging callus was fairly strong [31]. Thus, such combi-
nation (bone size defects and 14 days) gives better indication of the
ability of the new bone to grow across the bone defect and at the same
time allow the comparisons with similar studies that are concerned with
early bone formation. Regarding to the ratio of Solcoseryl to n-HAp
silica gel for mixture preparation, the use of 1:1 by volume ratio was
selected to provide equal chances for the action of both components and
to explore their preliminary effect.
According to the obtained results, the hypothesis proposed for the
current study was accepted; better bone healing quality and sig-
nificantly higher area percentage of the newly formed bone were found
when the Solcoseryl and n-HAp silica gel (NanoBone) mixture (SN
group) were grafted in the rabbit's skull defects as compared to the
control and the other experimental groups (Table 2 and Fig. 8). In an
attempt to explain this synergistic effect, it is important to understand
the underlying characteristics of each material that promote such be-
havior. The following discussion will be based on the fact that optimum
Fig. 2. Energy dispersive X-ray analyses (EDX) pattern with elemental percentages (Wt. & At. %) of n-HAp silica gel granules.
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Fig. 3. SE micrograph of two of n-HAp silica gel granules at different magnifications. (A) Two granules, one of a diameter of 214.5 μm and the other with a length of
436.3 μm. (B) The granule revealed high surface roughness. (C) The n-HAp crystals within the granule showed interconnected porosities (< 100 nm in diameter).
Fig. 4. TE micrograph of the embedded n-HAP granules in a matrix of silica gel (SiO2) having interconnecting pores at different magnifications (A, B). The sample is a
thin slice prepared by ultramicrotomy. Thus, it is embedded in epoxy resin where it is not possible to differentiate between silica gel and epoxy.
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bone grafting substitutes should promote new natural bone formation,
while being biodegradable in the same way as the natural bone and
porous to facilitate cell growth as well as vascularization [32,33].
Solcoseryl has been documented to have the ability to activate the
transport of oxygen and nutrients to cells, promotes their recovery and
oxygen consumption, stimulates ATP synthesis, and improves the pro-
liferation of reversibly damaged cells, principally in hypoxic conditions,
thereby accelerating the healing process. In other words, it strengthens
the intracellular energy transfer and increases stockpiles phosphates.
Stimulates the regenerative power of the tissues, promotes revascular-
ization of ischemic tissues, and also creates conditions conducive to the
synthesis of collagen and formation of granulation tissue [13–18]. This
has been supported by the histopathological findings among the S
group (Fig. 6B and C); where wide bone marrow cavities containing
dilated blood vessels were observed.
Meanwhile, the synthetic nano-hydroxy-appetite silica gel bone
graft material (NanoBone) used in the current study possessed the ad-
vantages of being chemically and structurally close to natural bone.
According to the EDX chemical analysis results (Fig. 2), the n-HAp silica
gel granules (NaonBone) possessed an average Ca: P ratio of 1.74 by At.
%. This ratio is similar to that of the hydroxyapatite crystals of natural
bone [34]. Additionally, the nanostructure of this synthetic bone sub-
stitute materials, is closely resemble the nanostructure and texture of
the natural HAp of bone with its subsequent enhanced cellular activity
and bone induction potential [33–36]. This was confirmed with the
SEM (Fig. 3A-C); where the single granule is formed of loosely packed
n-HAp crystals with very high surface roughness and interconnected
porosities (< 100 nm in diameter) that could facilitate bone cell ad-
hesion and patient's blood diffusion respectively. Furthermore, Nano-
Bone is produced by the sol-gel process [5]. During its manufacturing,
the temperature is always below 700 °C. Therefore, the nano-crystalline
hydroxyapatite is not sintered. In the sol-gel method, n-HAp is im-
pregnated into the SiO2-sol and homogeneously distributed. The silica
forms a nano-porous scaffold during gelation process and connects the
loosely packed n-HAp crystallites. During the drying process at 200 °C
(evaporation of the solvent), formation of pores in the micro and nano-
meter range occurs, producing a highly porous granulate [4–6]. This
has been confirmed by the SEM and the TEM as presented in Fig. 3B and
Fig. 4A-C, respectively. Because of the high porosity and loose packa-
ging of the n-HAp crystals within the granules, the solid content is
about 20 vol %. However, during the surgical operation, about 80 vol %
is filled with the patient's own blood components. Particularly, the
Fig. 5. TE micrograph of the matrix of the silica gel after partial dissolution of the n-HAp crystals with EDTA at different magnifications (A-C). The pore size
distribution of the interconnecting pores was around 20 nm.
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patient's own proteins can pass in the nano-pores of the bone graft
material [4–6]. These explanations have been supported by the histo-
pathological findings among the N group (Fig. 6D and E).
Consequently, the new bone area percent in all experimental groups
were significantly higher than the control group (left empty). The
highest significant area percentage of the newly formed bone was ob-
tained when Solcoseryl and n-HAp silica gel (NanoBone) mixture was
grafted (SN group) in the rabbit's skull defects; getting the advantage of
the nanostructured properties and chemical composition of NanoBone
granules and the high vascularization potential of Solcoseryl paste,
followed by the use of NanoBone granules alone (N group), and
Solcoseryl paste alone (S group) and finally, the control group in des-
cending order. This has been confirmed by the histopathological
findings among the SN group (Fig. 6F) and the histochemical results
presented in Fig. 7B.
From the clinical point of view, this animal study could introduce a
new combined treatment (Solcoseryl and NanoBone) that could accel-
erate postoperative physiological ingrowth of bone into dental implants
site, cystic bony defects or even extraction sockets. Additionally, such
combined treatment could facilitate bone regeneration after surgical
excision of large tumors where the surgical sites usually suffer from
insufficient blood supply due to underlying pathological conditions that
delay the healing process. However, further studies that consider ex-
tended testing periods (more than 14 days), and different combination
ratios of Solcoseryl and n-HAp silica gel, are recommended.
Fig. 6. (A) Photomicrograph of control (C) group showing the bony defect totally filled with connective tissue stroma, and area of osteoid tissue is observed (arrow)
(H&Ex200). (B) Photomicrograph of S group showing areas of osteoid tissue surrounded by plump cells and central calcification (arrows) (H&Ex200). (C)
Photomicrograph of S group showing thin trabeculae of bone enclosing wide marrow cavities (containing dilated blood vessels). Note, the separated bony spicule
(yellow arrow) and area of calcification within connective tissue stroma (black arrow) (H&Ex200). (D) Photomicrograph of N group showing numerous areas of
osteoid tissue surrounded by plump cells, with obvious central calcification (H&Ex400). (E) Photomicrograph of N group showing network of bone trabeculae
enclosing marrow spaces, Note, reversal lines (arrow) and osteocytes within their lacunae (H&Ex200). (F) Photomicrograph of SN group showing network of thick
bone trabeculae enclosing narrow marrow spaces, filled with fibro-vascular marrow. Note, numerous reversal lines (arrows) and osteocytes within their lacunae (H&
Ex200).
Fig. 7. (A) Photomicrograph of the control (C) group
showing the bony defects filled with connective
tissue stroma and surrounded by calcified compact
bone. (B) Photomicrograph of combined (SN) group
showing well calcified thick bone trabeculae, similar
to the normal bony margin (arrow). Decalcified bone
is only limited to the peripheries of osteocytic la-
cunae within bone trabeculae (Masson
Trichromex200).
Table 2
Mean and standard deviation (SD) values of the area percentage (%) of the newly formed bone among all groups.
Groups Control
(C)
Solcoseryl Paste
(S)
NanoBone Granules
(N)
Solcoseryl/NanoBone Mixture
(SN)
Mean (%)± SD 21.646 ± 4.95 45.215 ± 8.09 62.352 ± 10.1 69.927 ± 15.9
P-value 0.0001**
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5. Conclusions
The chemical composition and microstructure (interconnected
nano-porosities and the nano-textured surface roughness) of n-HAp si-
lica gel (NanoBone) granules provided biomimetic bone substitute
material that promotes new bone formation. Combination of Solcoseryl
and Nanobone (n-HAp silica gel) in a ratio of 1:1 vol % has a synergistic
osteoinductive effect quantitatively and qualitatively on bone forma-
tion.
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Fig. 8. Area percentage of newly formed bone among all groups.
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